BioArctic AB (OSTO:BIOA B) Institutional Ownership : 16.15% (As of May. 24, 2024)

View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BioArctic AB's institutional ownership is 16.15%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BioArctic AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BioArctic AB's Float Percentage Of Total Shares Outstanding is 0.00%.

BioArctic AB Institutional Ownership Historical Data

The historical data trend for BioArctic AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Institutional Ownership Chart

BioArctic AB Historical Data

The historical data trend for BioArctic AB can be seen below:

	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30
Institutional Ownership	16.20	16.26	16.21	16.34	16.44	16.54	16.25	15.97	16.02	16.15

BioArctic AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

BioArctic AB (OSTO:BIOA B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

BRCTF:USA 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB (OSTO:BIOA B) Headlines

No Headlines